Director at Cognex (CGNX) exercises options and sells 177K shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cognex director Robert Willett reported exercising stock options and selling the resulting shares on 02/12/2026. He exercised options for 173,296 shares at $38.39 and 3,756 shares at $39.44, then sold all 177,052 shares of common stock at an average price of $58.3851 per share in open-market transactions.
The filing shows remaining direct holdings of multiple non-qualified stock options covering hundreds of thousands of shares with exercise prices from $33.04 to $90.5, plus 70,824 restricted stock units and 15,804 shares held indirectly by a trust where Willett is trustee and beneficiary. The stock option exercises were carried out under a pre-established Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 177,052 shares ($10,337,199)
Net Sell
15 txns
Insider
Willett Robert
Role
Director
Sold
177,052 shs ($10.34M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) | 173,296 | $0.00 | -- |
| Exercise | Non-Qualified Stock Option (right to buy) | 3,756 | $0.00 | -- |
| Exercise | Common Stock | 173,296 | $38.39 | $6.65M |
| Sale | Common Stock | 173,296 | $58.3851 | $10.12M |
| Exercise | Common Stock | 3,756 | $39.44 | $148K |
| Sale | Common Stock | 3,756 | $58.3851 | $219K |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Non-Qualified Stock Option (right to buy) | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Non-Qualified Stock Option (right to buy) — 0 shares (Direct);
Common Stock — 173,296 shares (Direct);
Restricted Stock Unit — 70,824 shares (Direct);
Common Stock — 15,804 shares (Indirect, by Trust)
Footnotes (1)
- These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The reporting person is a trustee and beneficiary of Willett Parkhill Investment Trust dated August 2, 2010. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
FAQ
What insider transaction did Cognex (CGNX) director Robert Willett report?
Robert Willett reported exercising Cognex stock options and immediately selling the resulting common shares. He exercised 177,052 options and sold 177,052 shares at an average price of about $58.3851 per share in open-market transactions on 02/12/2026.
Were Robert Willett’s Cognex (CGNX) option exercises under a Rule 10b5-1 plan?
Yes. The filing states the stock option exercises were effected under a trading plan adopted in accordance with Rule 10b5-1. Such plans pre-schedule trades, allowing insiders to sell shares according to preset instructions regardless of later market conditions.
What Cognex (CGNX) equity awards does Robert Willett still hold after these transactions?
After these transactions, he holds several non-qualified stock options over common stock with various exercise prices and expiration dates, along with 70,824 restricted stock units. He also has indirect ownership of 15,804 Cognex shares through a trust reported in the filing.
What types of Cognex (CGNX) derivative securities are listed for Robert Willett?
The document lists multiple non-qualified stock options giving Willett the right to buy Cognex common stock at exercise prices from $33.04 to $90.5, with expiration dates between 2027 and 2035. It also includes 70,824 restricted stock units scheduled to vest over time.